Ondine Biomedical Future Growth

Future criteria checks 2/6

Ondine Biomedical is forecast to grow earnings and revenue by 28% and 66% per annum respectively while EPS is expected to grow by 43.2% per annum.

Key information

28.0%

Earnings growth rate

43.2%

EPS growth rate

Medical Equipment earnings growth22.5%
Revenue growth rate66.0%
Future return on equityn/a
Analyst coverage

Low

Last updated12 Nov 2024

Recent future growth updates

Recent updates

Is Ondine Biomedical (LON:OBI) In A Good Position To Invest In Growth?

Sep 28
Is Ondine Biomedical (LON:OBI) In A Good Position To Invest In Growth?

Earnings and Revenue Growth Forecasts

AIM:OBI - Analysts future estimates and past financials data (CAD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202612-28-27-251
12/31/20256-30-23-242
12/31/20243-15-20-132
6/30/20242-14-13-13N/A
3/31/20241-14-13-13N/A
12/31/20231-14-14-14N/A
9/30/20231-17-15-15N/A
6/30/20231-19-16-16N/A
3/31/20231-19-16-16N/A
12/31/20221-19-17-16N/A
9/30/20221-37-18-18N/A
6/30/20221-54-19-19N/A
3/31/20222-52-16-16N/A
12/31/20213-50-13-13N/A
12/31/20202-16-6-6N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: OBI is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: OBI is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: OBI is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: OBI's revenue (66% per year) is forecast to grow faster than the UK market (3.6% per year).

High Growth Revenue: OBI's revenue (66% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if OBI's Return on Equity is forecast to be high in 3 years time


Discover growth companies